Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07315035
Brief Title:
QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer
Official Title:
A Randomized, Controlled, Phase-II Trial of Neoadjuvant QL1706 (Iparomlimab /Tuvonralimab) Combined With SOX Versus SOX Alone Followed by Curative Gastrectomy in Patients With Locally Advanced Diffuse-Type Gastric Adenocarcinoma
Study:
NCT07315035
Protocol Section:
NCT07315035